CCL18 and colorectal carcinoma: To further confirm the accuracy and reliability of the above bioinformatics analysis, SFTPD, one of the three hub genes (CLU, SFTPD and CCL18) that was not only specifically boosted in lung metastatic CRC compared with liver metastases, but also significantly correlated to poor prognosis of CRC patients, was selected for subsequent functional experiment.